Christopher S. Miller is a partner in the Berwyn office of Pepper Hamilton LLP. He concentrates his practice in the areas of mergers and acquisitions, private equity, venture capital, securities, technology law and general corporate matters. Mr. Miller’s principal focus is in the life sciences industry.
Mr. Miller regularly represents public and private companies and private equity funds in merger and acquisition transactions. He also represents private equity funds and emerging companies in venture capital, growth equity and debt financing transactions, including numerous financings of LLC’s. Mr. Miller represents companies in private and public securities offerings, as well as public companies in ongoing reporting and compliance matters. He also regularly counsels companies in the life sciences industry on general corporate matters and in connection with licensing, collaboration and other commercial agreements.
The following engagements are representative of Mr. Miller’s practice. He has participated in the representation of:
- numerous private equity and venture capital funds in connection with investments in life science and biotechnology companies, including:
- a private equity syndicate in connection with a $45 million growth equity investment in a pharmaceutical industry company
- a venture capital syndicate in connection with a $24 million investment in a specialty pharmaceutical company
- a national venture capital fund’s $17 million investment in a pharmaceutical services technology company
- a private equity fund’s $8 million sub-debt investment in a medical products company
- a specialty pharmaceutical company in connection with its initial public offering
- a public specialty pharmaceutical company in connection with its acquisition by a public pharmaceutical company
- a pharmaceutical staffing company in connection with its $10 million private equity and sub-debt financing
- a privately held specialty pharmaceutical company in connection with its $35 million acquisition by a publicly held Canadian pharmaceutical company.
Mr. Miller is an adjunct professor in the graduate program of Lehigh University’s College of Business and Economics where he teaches a class on venture capital. He also lectures regularly to private equity and venture capital organizations.
Mr. Miller is a former member of the staff of the U.S. Securities and Exchange Commission, where he worked just prior to joining Pepper in 1997.
